A U.S. court has issued its final ruling in a high-profile case involving the death of the well-known “Friends” actor, following extensive investigations that revealed a doctor’s involvement in administering a fatal dose of ketamine. The verdict came after the court determined that the physician had injected the actor with an excessively high dose during a treatment session that failed to meet established medical standards, ultimately leading to respiratory failure and fatal complications.
Case records showed that the actor had been undergoing private therapeutic sessions intended to help manage psychological stress. However, the doctor in charge violated safety protocols, administering ketamine — a potent substance that affects the central nervous system — without adhering to the strict monitoring and medical supervision required when using such drugs.
Investigations further revealed that the doctor not only administered an unsafe dose but also left the actor without continuous observation, a factor the court described as gross negligence and a serious breach of professional responsibility. Medical reports noted that delayed emergency intervention contributed significantly to the actor’s deteriorating condition and the inability to save his life.
Based on the evidence presented, the court sentenced the doctor to prison, revoked his medical license for a defined period, and required him to complete rehabilitation and medical safety programs. The ruling emphasized the importance of strict regulation and oversight regarding the use of high-risk psychoactive medications, as well as the need for full compliance with medical safety standards to prevent similar incidents.
The case has renewed public attention on the dangers of improper handling of powerful medical substances and highlighted the critical need for professional supervision and advanced clinical environments to ensure patient safety during sensitive therapeutic treatments.
